Medical device maker Medtronic is advising doctors and patients to pay close attention to all malfunction alarms on implantable SynchroMed II drug pumps because of a problem that has caused a handful ...

Medtronic’s SynchroMed II implantable drug pump device, which has been recalled three times in recent years and tied to 14 deaths, has continued to be problematic for the medtech company. A three-page ...

MINNEAPOLIS--(BUSINESS WIRE)-- As part of its ongoing commitment to keep patients and physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) is issuing an urgent Medical ...

170 cases of hyperglycemia and 11 cases of diabetic ketoacidosis reported between January 2023 and September 2024 in the US. FDA classifies recall as class I due to potential for serious health risks.

The FDA Dec. 17 classified Medtronic’s recall of its implanted drug pumps as Class I, the most serious type of recall, according to MassDevice. Medtronic originally recalled 11,299 of its pumps, ...

CHICAGO (Reuters) - Medtronic Inc has sent a letter to physicians warning about possible reduced battery performance in a small percentage of its SynchroMed II Implantable Drug Infusion Pumps, the ...

Medtronic is recalling several models of its MiniMed insulin pumps because of a risk that hackers could take control and change their settings. The FDA said diabetics should talk with their doctors ...

With a great deal of hype, and a few delays from the US Food and Drug Administration (FDA), Medtronic in September 2013 released its newest combined pump and continuous glucose monitor (CGM), the ...

(CN) - A New Jersey man who relied on a Medtronic device to administer the proper dose of insulin while he slept slipped into a fatal diabetic attack, his estate claims in court. Diagnosed with Type 1 ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...